NCT03678883 2026-04-039-ING-41 in Patients With Advanced CancersActuate Therapeutics Inc.Phase 2 Active not recruiting350 enrolled
NCT02489903 2025-03-17RRx-001 in Lung Cancer, Ovarian Cancer and Neuroendocrine Tumors Prior to Re-administration of Platinum Based Doublet Regimens (QUADRUPLE THREAT)EpicentRx, Inc.Phase 2 Completed139 enrolled 14 charts
NCT04244552 2023-12-29A Phase 1b Trial of ATRC-101 in Adults With Advanced Solid MalignanciesAtreca, Inc.Phase 1 Terminated87 enrolled
NCT00859495 2020-08-25Trimodal Lung-Sparing Treatment of Pleural MesotheliomaColumbia UniversityPhase 2 Terminated9 enrolled 4 charts
NCT02331251 2018-07-02Study of Pembrolizumab Plus Chemotherapy in Patients With Advanced Cancer (PembroPlus)Western Regional Medical CenterPhase 1/2 Terminated81 enrolled
NCT02262455 2017-02-13Effects of STM 434 Alone or in Combination With Liposomal Doxorubicin in Patients With Ovarian Cancer or Other Advanced Solid TumorsSanta Maria BiotherapeuticsPhase 1 Completed32 enrolled
NCT00886028 2009-04-22Palliative Treatment With Liposomal Doxorubicin Plus Cisplatin for Patients With Malignant Pleural MesotheliomaNational Institute of CancerologíaPhase 2 Unknown31 enrolled